$-0.13 EPS Expected for Ekso Bionics Holdings, Inc. (EKSO); Goldfield (GV) Sentiment Is 0.82

October 27, 2017 - By Vivian Currie

The Goldfield Corporation is engaged in the construction of electrical infrastructure for the utility industry and industrial customers. The company has market cap of $142.53 million. The Firm serves clients in the Southeast and mid-Atlantic regions of the United States, including Texas. It has a 14.14 P/E ratio. It operates through electrical construction segment.

Analysts expect Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) to report $-0.13 EPS on November, 8.They anticipate $0.38 EPS change or 74.51% from last quarter’s $-0.51 EPS. After having $-0.32 EPS previously, Ekso Bionics Holdings, Inc.’s analysts see -59.38% EPS growth. The stock decreased 2.73% or $0.03 on October 27, reaching $1.07. About 299,024 shares traded. Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) has declined 70.28% since October 27, 2016 and is downtrending. It has underperformed by 86.98% the S&P500.

It closed at $5.6 lastly. It is down 77.87% since October 27, 2016 and is uptrending. It has outperformed by 61.17% the S&P500.

Thomson Horstmann & Bryant Inc holds 0.68% of its portfolio in Goldfield Corp for 950,592 shares. Ativo Capital Management Llc owns 191,021 shares or 0.29% of their US portfolio. Moreover, Bogle Investment Management L P De has 0.19% invested in the company for 470,617 shares. The Michigan-based Seizert Capital Partners Llc has invested 0.09% in the stock. Menta Capital Llc, a California-based fund reported 91,835 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com